| http://www.w3.org/ns/prov#value | - Pfizer and other big pharmaceutical companies lobbied very aggressively against any move by the WHO to create global norms for setting R&D priorities, to identify mechanisms for sustainable funding for R&D, or to design R&D mechanisms that do not create barriers for access.
|
